Sandbox Reserved 1172: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 22: Line 22:


=== Sphingosine 1-Phosphate Receptor ===
=== Sphingosine 1-Phosphate Receptor ===
LPA<sub>1</sub> belongs to the EDG (endothelial differentiation gene) family of [https://en.wikipedia.org/wiki/Lysophospholipid_receptor lysophospholipid receptors]. This family also includes the [https://en.wikipedia.org/wiki/S1PR1 sphingosine 1-phosphate receptor 1] (S1P<sub>1</sub>), which shares many structural similarities to LPA<sub>1</sub>. In fact, the transmembrane regions share a sequence identity of 41%. <ref name = 'Chun, E.'>Chun, E., Thompson, A.A., Lui, W., Roth, C.B., Griffith, M.T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M.A., and Stevens, R.C. “Fusion partner tool chest for the stabilization and crystallization of G protein-coupled receptors.” Structure 20, (2012) 967-976.' </ref> A defining difference between these two receptors is their mode of ligand access to the binding site. The hydrophobic [https://en.wikipedia.org/wiki/Sphingosine-1-phosphate S1P ligand] enters S1P<sub>1</sub> via the membrane. LPA<sub>1</sub> differs and utilizes an extracellular opening that allows LPA access from the extracellular space (Figure 2). <ref name="regpeps">PMID: 26091040</ref> Structural evidence for this altered ligand binding pathway includes global changes in the positioning of the extracellular loops (ECL) and transmembrane helices (TM). Specifically, a slight divergence of <scene name='72/721543/Tmvii_and_tmi/1'>TMI</scene>, which is positioned 3 Å closer to TMVII compared to S1P<sub>1</sub>, and a repositioning of <scene name='72/721543/Ecl_regions/1'>ECL3</scene>, resulting in a divergence of 8 Å from S1P<sub>1</sub> result in ligand access via the extracellular space. <ref name="regpeps">PMID: 26091040</ref> This narrowing of the gap between TMI and TMVII blocks membrane ligand access, while the greater distance between ECL3 and the other extracellular loops promotes extracellular access for LPA<sub>1</sub>. Additionally, ECL0 is helical in S1P<sub>1</sub>, but <scene name='72/721543/Ecl02ndstructure/1'>lacks secondary structure</scene> in LPA<sub>1</sub>. This increased flexibility that results further promotes favorable access from the extracellular space. <ref name="regpeps">PMID: 26091040</ref>
LPA<sub>1</sub> belongs to the EDG (endothelial differentiation gene) family of [https://en.wikipedia.org/wiki/Lysophospholipid_receptor lysophospholipid receptors]. This family also includes the [https://en.wikipedia.org/wiki/S1PR1 sphingosine 1-phosphate receptor 1] (S1P<sub>1</sub>), which shares many structural similarities to LPA<sub>1</sub>. In fact, the transmembrane regions share a sequence identity of 41%. <ref name = 'Chun, E.'>Chun, E., Thompson, A.A., Lui, W., Roth, C.B., Griffith, M.T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M.A., and Stevens, R.C. “Fusion partner tool chest for the stabilization and crystallization of G protein-coupled receptors.” Structure 20, (2012) 967-976.' </ref> A defining difference between these two receptors is their mode of ligand access to the binding site. The hydrophobic [https://en.wikipedia.org/wiki/Sphingosine-1-phosphate S1P ligand] enters S1P<sub>1</sub> via the membrane. LPA<sub>1</sub> differs and utilizes an extracellular opening that allows LPA access from the extracellular space (Figure 3). <ref name="regpeps">PMID: 26091040</ref> Structural evidence for this altered ligand binding pathway includes global changes in the positioning of the extracellular loops (ECL) and transmembrane helices (TM). Specifically, a slight divergence of <scene name='72/721543/Tmvii_and_tmi/1'>TMI</scene>, which is positioned 3 Å closer to TMVII compared to S1P<sub>1</sub>, and a repositioning of <scene name='72/721543/Ecl_regions/1'>ECL3</scene>, resulting in a divergence of 8 Å from S1P<sub>1</sub> result in ligand access via the extracellular space. <ref name="regpeps">PMID: 26091040</ref> This narrowing of the gap between TMI and TMVII blocks membrane ligand access, while the greater distance between ECL3 and the other extracellular loops promotes extracellular access for LPA<sub>1</sub>. Additionally, ECL0 is helical in S1P<sub>1</sub>, but <scene name='72/721543/Ecl02ndstructure/1'>lacks secondary structure</scene> in LPA<sub>1</sub>. This increased flexibility that results further promotes favorable access from the extracellular space. <ref name="regpeps">PMID: 26091040</ref>




[[Image:ECL3DistanceCM.png|200 px|left|thumb|Figure 1: Extracellular ligand access pathway on LPA<sub>1</sub>. Compared to S1P<sub>1</sub>, ECL3 shown in red is positioned 8 Å further from ECL0 and ECL2 shown in green. This largely contributes to the altered ligand binding pathway between LPA<sub>1</sub>, and S1P<sub>1</sub>]]
[[Image:ECL3DistanceCM.png|200 px|left|thumb|Figure 3: Extracellular ligand access pathway on LPA<sub>1</sub>. Compared to S1P<sub>1</sub>, ECL3 shown in red is positioned 8 Å further from ECL0 and ECL2 shown in green. This largely contributes to the altered ligand binding pathway between LPA<sub>1</sub>, and S1P<sub>1</sub>]]


=== Endocannabinoid Receptor 1 ===
=== Endocannabinoid Receptor 1 ===
Line 32: Line 32:
<scene name='72/721543/Asp129_and_trp210/2'>Residues Asp129 and Trp210</scene> located within the hydrophobic binding pocket of LPA<sub>1</sub> may share responsibility for the preference for long unsaturated acyl chains. These residues are also interesting in regard to GPCR phylogenic evolution. <ref name="regpeps">PMID: 26091040</ref> Trp210 specifically only occurs in this position in 1% of all class A GPCR receptors and is unique to lysophospholipid and cannabinoid receptors. <ref name = 'Van Durme'>Van Durme, J., Horn, F., Costagliola, S., Vriend, G., and Vassart, G. “GRIS: glycoprotein-hormone receptor information system.” Mol. (2006) Endocrinol. 20, 2247-2255' </ref>
<scene name='72/721543/Asp129_and_trp210/2'>Residues Asp129 and Trp210</scene> located within the hydrophobic binding pocket of LPA<sub>1</sub> may share responsibility for the preference for long unsaturated acyl chains. These residues are also interesting in regard to GPCR phylogenic evolution. <ref name="regpeps">PMID: 26091040</ref> Trp210 specifically only occurs in this position in 1% of all class A GPCR receptors and is unique to lysophospholipid and cannabinoid receptors. <ref name = 'Van Durme'>Van Durme, J., Horn, F., Costagliola, S., Vriend, G., and Vassart, G. “GRIS: glycoprotein-hormone receptor information system.” Mol. (2006) Endocrinol. 20, 2247-2255' </ref>


A model for lipid agonist binding generated through molecular modeling was used to dock two of the cannabinoid receptor CB<sub>1</sub>'s most abundant endogenous ligands into the LPA<sub>1</sub> binding pocket. <ref name="regpeps">PMID: 26091040</ref> Rotameric shifts of Trp210 and Trp271 leading to expansion of the binding pocket and the exposure of the π clouds of their indole rings provided favorable interactions with the double bonds of the phosphorylated cannabinoid ligands. This favorable binding provides evidence that the hydrophobic binding pockets of LPA<sub>1</sub> and CB<sub>1</sub> are able to favorably bind the same poly-unsaturated acyl chains with metabolically interconvertible head groups. <ref name="regpeps">PMID: 26091040</ref>
A model for lipid agonist binding generated through molecular modeling was used to dock two of the cannabinoid receptor CB<sub>1</sub>'s most abundant endogenous ligands into the LPA<sub>1</sub> binding pocket. <ref name="regpeps">PMID: 26091040</ref> Rotameric shifts of Trp210 and Trp271 leading to expansion of the binding pocket and the exposure of the π clouds of their indole rings provided favorable interactions with the double bonds of the phosphorylated cannabinoid ligands (Figure 4). This favorable binding provides evidence that the hydrophobic binding pockets of LPA<sub>1</sub> and CB<sub>1</sub> are able to favorably bind the same poly-unsaturated acyl chains with metabolically interconvertible head groups. <ref name="regpeps">PMID: 26091040</ref>
[[Image:TrpRotamericShiftsCM.png|200 px|left|thumb|Figure 1: Illustration of key LPA<sub>1</sub> binding pocket residues Trp210 and Trp271. These residues provide rotameric shifts and expansion that allow for favorable interactions with phosphorylated cannabinoid ligands.]]
[[Image:TrpRotamericShiftsCM.png|200 px|left|thumb|Figure 4: Illustration of key LPA<sub>1</sub> binding pocket residues Trp210 and Trp271. These residues provide rotameric shifts and expansion that allow for favorable interactions with phosphorylated cannabinoid ligands.]]


== Disease Relevance ==
== Disease Relevance ==